Sponsored
Adding artificial intelligence (AI) to legacy pharma supply chain systems requires auditable human intelligence to fix data and trust gaps.
Mark Talens, Chief Commercial Officier
Advertisement
Articles by Mark Talens, Chief Commercial Officier
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech
2
What Supply Chain Resilience Actually Requires in a Volatile Global Market: LogiPharma2026
3
Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs
4
MFN Raises the Stakes for Japan Launch Pricing
5